6 Recruiting Acute Myeloid Leukemia, in Relapse Phase 1 Clinical Trials
Active phase 1 studies for acute myeloid leukemia, in relapse enrolling across the USA. Verify eligibility and contact site coordinators.
All Acute Myeloid Leukemia, in Relapse studiesPhase 1 Studies for Acute Myeloid Leukemia, in Relapse
🔵 Active, Not Recruiting Phase1
Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
📍 Novant Health Cancer Institute — Charlotte, North Carolina
View Study & Checklist ➔ 🟢 Recruiting Phase1
Venetoclax to Augment Epigenetic Modification and Chemotherapy
📍 Children's Wisconsin — Milwaukee, Wisconsin
View Study & Checklist ➔ 🟢 Recruiting Phase1
A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)
📍 Scripps Green Hospital — La Jolla, California
View Study & Checklist ➔ 🟢 Recruiting Phase1
Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
📍 University of Virginia Cancer Center — Charlottesville, Virginia
View Study & Checklist ➔ 🟢 Recruiting Phase1
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
📍 City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center) — Duarte, California
View Study & Checklist ➔